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Abstract 
 
Background and aims: Antibiotic prophylaxis in surgery is known to reduce the rate of surgical site 
infections (SSI) as well as shorten hospital stay. However, there is currently a scarcity of data on 
antibiotic prophylaxis and SSIs among African countries including Botswana. Consequently, this study 
aimed to address this. Methods: A prospective study involving 400 patients was carried out at a 
leading tertiary hospital in Botswana from 2014-2015.  PatiHQWV¶GHPRJUDSKLFLQIRUPDWLRQW\SHRI
surgery performed and peri-operative use of antibiotics were documented. All enrolled patients were 
followed-up for 30 days post discharge to fully document the incidence of SSIs. Results: Median age 
of patients was 35.5 (25 ± 50) years, with 52% female. There were 35.8% emergency and 64.2 % 
elective surgeries. The most common operations were exploratory laparotomy (25%), appendectomy 
(18.3%), excision and mastectomy (8%). Antibiotics were given in 73.3% of patients, mainly 
postoperatively (58.3%). The most commonly prescribed antibiotics were cefotaxime (80.7%), 
metronidazole (63.5%), cefradine (13.6%) and amoxicillin/clavulanate (11.6%). The incidence of SSI 
was 9%. The most common organisms were Pseudomonas aeruginosa, Staphylococcus aureus, and 
coagulase-negative staphylococci. Conclusion: The rate of SSI is a concern, and may be related to 
inappropriate antibiotic prophylaxis given post operatively. Interventions are in place to decrease SSI 
rates to acceptable levels in this leading hospital by improving for instance infection prevention 
practices including the timing of antibiotic prophylaxis. Research is also ongoing among other 
hospitals in Botswana to reduce SSI rates building on these findings. 
  
Introduction 
 
Surgical site infections (SSI) are infections related to the operative procedure that occurs at or near 
the surgical incision within 30 days of the procedure (up to one year if a prosthetic material is 
implanted), and affecting either the incision or deep tissue at the operation site or any part of the 
anatomy (e.g., organs and spaces) [1-3]. They are among the common causes of hospital acquired 
infections, which appreciably add to post-operative morbidity and mortality, prolong hospital stay by 
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up to 7 to 11 post-operative days, and increase costs [3-5]. Patients with SSIs can increase their 
mortality by up to 11-fold, with SSI costing up to US$10bn/ year across countries [5, 6]. The incidence 
of SSI ranges from under 1% to over 50% depending on population studied, type of surgery, size of 
hospital, ventilation within the hospital, experience of the surgeon and surveillance method [3, 7-10]. 
In a  meta-analysis, Ngaroua et al reported a pooled incidence rate of SSI of  14.8% in Africa [11], 
with SSIs appearing particularly problematic and common in lower and middle income countries 
(LMICs) versus high income countries [12]. 
 
The pattern of occurrence of SSI is based on the distribution and virulence of the offending organisms 
and host resistance [13].  Common causative organisms of SSI include staphylococcus species, 
Escherichia coli, Pseudomonas aeruginosa and Klebsiella species [10, 14-16]. Polymicrobial 
existence is common in SSIs [15, 16]. Risk factors for development of SSI include the degree of 
tissue trauma, pre-operative infection, presence of a prosthesis or other foreign body, surgical 
technique, length of surgery and its complexity, re-interventions, reduced fitness, use of steroids, lack 
of adherence to agreed prescribing guidance and a prolonged duration of surgery [10, 13, 17-19]. 
  
Over the years, surgery has been made safer by modifying these factors through measures such as 
aseptic surgical techniques, skin cleansing prior to surgery, pre-operative patient preparation, 
optimization of co-morbid illnesses and by administering surgical antibiotic prophylaxis [13, 20]. 
Surgical antibiotic prophylaxis reduces the burden of microorganisms at the surgical site and has 
been shown to be a cost-effective strategy in reducing the rate of SSI and shortening hospital stay 
[13, 21, 22]. Overall, up to  60% of SSIs are preventable using evidence based approaches [6]. The 
use of antibiotics has been shown to decrease SSI by 39 % [23]. Guidelines recommend that 
antibiotic prophylaxis be given within 1-2 hours before incision, and in doses sufficient to achieve 
adequate serum and tissue drug levels for the interval during which the surgical site is open [6, 17, 
20, 22, 24-26]. In cases where the duration of the surgery exceeds 2 half-lives of the antimicrobial or 
there is excessive blood loss, intraoperative re-dosing is needed to maintain adequate serum and 
tissue drug levels [27].  However, initiating antibiotics after the first incision is not advised as it almost 
doubles SSI rates [28].  Moreover, prolongation of antibiotic prophylaxis after the operation is not 
recommended as it predisposes to resistance [26, 29].  Continued surveillance and appropriate 
strategies can appreciably reduce the prevalence of SSIs, which include the monitoring of clinical 
practice against agreed guidance [30]. Such strategies are becoming increasingly important.  
 
Antibiotic selection is often based on the risk of wound infection according to wound classification, the 
normal floral distribution of the site to be operated and the antibiotic resistance patterns in the hospital 
setting [1, 6, 17, 25, 27, 31, 32]. Generally, broad-spectrum antibiotics are preferred to narrow 
spectrum antibiotics and cephalosporin are commonly used [27].  Cefazolin is commonly 
recommended for gastroenterological, genito-urinary tract, and hepatobiliary surgeries [27]. The 
Botswana national guidelines recommend cefradine for cardiothoracic, neurosurgery, 
gastroenterological, vascular surgeries, breast, orthopaedic and gynaecological surgeries [33]. A 
combination of ampicillin, gentamicin and metronidazole is recommended for high risk biliary surgery, 
and a combination of gentamicin and ciprofloxacin for  urological surgeries [33]. Despite these 
recommendations, studies have shown inconsistencies in administering surgical prophylaxis in for 
instance the proportion of surgical patients to whom prophylaxis is prescribed, type of the antibiotic 
chosen, time of administration and duration of the antibiotic course [17, 26]. In addition, there is 
paucity of information regarding the burden of SSI and prophylactic regimens used in developing 
countries; although, as mentioned, these are likely to be more problematic in LMICs [7, 12].  
 
Aims 
 
We sought to address the lack of knowledge regarding SSIs in Botswana by describing their current 
burden and the antibiotic surgical prophylactic patterns in a leading hospital in Botswana. The findings 
would act as a basis for developing future pertinent strategies to reduce the number of SSIs in this 
hospital and wider in Botswana. This is particularly important in Botswana with its high incidence of 
infectious diseases, e.g. 21.9% of the adult population currently have HIV although this rate is 
decreasing [34].  
 
  
 3 
 
Methodology 
 
Study setting and participants  
This prospective cross-sectional study was conducted at Princess Marina Hospital (PMH) in 
Gaborone, between February 2014 and June 2015. PMH is the main public hospital in the country 
with a 560-bed capacity and an average of 12 general surgical operations every day. Consequently, if 
there were concerns with surgical prophylaxis in this hospital, such concerns or worse are highly likely 
at secondary hospitals in Botswana. We only included adult patients who underwent surgery, resided 
within a perimeter of 50 kilometres from PMH and with whom home visits were possible in view of our 
follow-up regime. We excluded children in this first study as adults are the largest population as well 
as patients with prostheses or implants. 
  
Data collection 
The information obtained from all enrolled patients included: demographic characteristics, 
anthropometric measurements, surgical diagnoses, comorbid conditions and the duration of 
antibiotics use. Other information included the type and time of prophylactic antibiotic administration. 
Enrolled patients were followed up for 30 days after the surgical procedure to assess the development 
of SSI. While in the wards, patients were assessed for the development of signs and symptoms of SSI 
once every two days until hospital discharge. We assessed for fever (>380C), abnormal wound 
discharge, increasing pain or tenderness, redness, heat or localized swelling/ abscess. Radiological, 
histological and clinical diagnoses of wound infection made by the attending doctor were also 
documented.  
 
After discharge, patients were physically assessed for SSIs through home visits or an arranged 
hospital visit during the first week post-discharge the hospital. Thereafter, patients were contacted 
through telephone calls twice every week until the 30th day post discharge to determine the 
development of any SSIs. During the phone calls, patients were asked if they had any symptoms of a 
SSI as described above. For those with any of the SSI symptoms, we arranged physical examination 
and pus swabs for microbiological examination. The diagnosis of an SSI was made on the presence 
of one or more of the following: purulent exudate from a surgical site, positive fluid culture - from a 
surgical site that was closed primarily; reopened surgical site due to at least one clinical sign of 
infection (pain, swelling, erythema, warmth) - culture positive or not cultured; or surgeon's diagnosis of 
infection. Patients with SSIs were referred to the responsible unit at PMH where they were managed 
accordingly.  
 
Statistical analysis 
The sample size was calculated from the assumption that the incidence of SSIs in Botswana 
was15%, and an expected loss to follow up of 30% [11]. We needed 400 patients to determine the 
true incidence with a margin of error of ± 4 % using a 95% confidence interval. Data were analysed 
using SPSS Version 23.0 for Windows (SPSS Inc., Chicago, IL, USA). Normally distributed variables 
were expressed as mean ± standard deviation (SD) and asymmetrically distributed variables were 
presented as median [interquartile range (IQR)]. We present categorical and nominal variables as 
DEVROXWHDQGUHODWLYHIUHTXHQFLHV7KH3HDUVRQ¶VȤWHVWZDVXVHGWRFRQWUDVWFDWHJRULFDO data. 
We considered a two sided p value of < 0.05 to be statistically significant. 
 
Ethical consideration  
The study was granted ethical clearance by the University of Botswana, Ministry of Health and PMH 
Institutional Review Boards. Written informed consent was obtained before data collection from all 
participants or their relatives in the cases where the patient was incapacitated to consent.  
 
Results 
 
In total, 400 patients with a median age of 35.5 (IQR 25-50) years were enrolled in the study. 
Demographic profile of the participants including their co-morbidities is shown in Table 1. There were 
143 (35.8%) emergency and 257 (64.2 %) elective surgeries. The most common operations 
performed were explorative laparotomy (25%), appendectomy (18.3%), excisions and mastectomy 
(8%). 
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Table 1: Clinical and demographic characteristics of enrolled surgical patients at Princess Marina 
Hospital in Botswana, N=400 
 
Characteristics 
Emergency Elective Total 
143 cases 257 cases 400 cases 
sex ² n (%) Female 50 (35.0) 159 (61.9) 209(52.3) 
Male 90 (62.9) 98 (38.1) 191 (49.7) 
Age ² years, median (IQR) 43 (29-55) 26 (22-36) 35.5 (25-50) 
Surgeries² n (%) 
Explorative laparotomy 74(51.7) 26(10.1) 100 (25.0) 
Appendectomy 66(46.2) 7(2.7) 73 (18.3) 
Excision 1(0.7) 49(19.1) 50 (12.5) 
Mastectomy 0 32 (12.5) 32 (8.0) 
Herniorraphy  3 (2.1) 25 (9.7) 28 (7.0) 
Hydrocoelectomy 2 (1.4) 19 (7.4) 21 (5.3) 
Cholecystectomy 1 (0.7) 20 (7.8) 21 (5.3) 
Orchiectomy 5(3.5) 12 (4.7) 17 (4.3) 
Mammoplasty 0 15 (5.8) 15 (3.8) 
Knee amputation 0 12 (4.7) 12 (3) 
Others 10 (7.0) 44 (17.1) 54 (11.3) 
Co-morbidities² n (%) 
HIV 21 (14.7) 56 (21.8) 77 (19.5) 
Hypertension  7 (4.9) 55 (21.4) 62 (15.6) 
Cancer  0 41 (16.0) 41 (10.3) 
Tuberculosis 2 (1.4) 2 (0.8) 4 (1) 
Diabetes 2 (1.4) 20 (7.8) 22 (5.5) 
NB: IQR = Interquartile range 
 
Antibiotic use 
Overall, 293(73.3%) cases were prescribed antibiotics. Sixty (15%) patients received antibiotics pre-
operatively, 233 (58.3%) patients post-surgery, and 107(26.8%) patients were not prescribed any 
antibiotics (Table 2).  
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Pre-operative antibiotics were prescribed in 31 (21.7%) emergency surgeries as compared to 29 
(11.3%) elective surgeries (P= 0.005). Post-operative antibiotics were prescribed in 132 (92.3%) 
emergency surgeries as compared to 144 (56%) elective surgeries (P < 0.001). Of the patients who 
started antibiotics postoperatively, established infections was suspected in those with peritonitis (8 
cases), abscesses (4 cases) and appendicitis (50 cases). The mean (SD) duration of post-operative 
antibiotic use was 5 (2.6) days. The most common prescribed antibiotics were cefotaxime (80.7%), 
metronidazole (63.5%), cefradine (13.6%) and amoxicillin/clavulanate (11.6%). Co-administration of 
cefotaxime and metronidazole was found in 134 (48.6%) patients post-operatively. Oral antibiotics 
such as cloxacillin, amoxicillin, doxycycline and metronidazole were also prescribed. 
 
Table 2: Antibiotic prophylaxis among surgical patients at Princess Marina Hospital in Botswana. 
 
Antibiotics ² 
n (%) 
All  Pre-operative Post-operative 
 Emergency Elective Emergency Elective 
293 cases 31 cases 29 cases 104 cases 129 cases 
Cefotaxime  220(80.7) 17(54.8) 16(55.2) 88(84.6) 99(76.7) 
Metronidazole 186(63.5) 15(48.4) 6(20.7) 90(86.5) 75(58.1) 
Cefradine 40(13.6) 8(25.8) 13(44.8) 11(10.6) 8(6.2) 
Amoclav 34(11.6) 0 0 14(13.5) 20(15.5) 
Amoxicillin 17(5.8) 0 0 2(1.9) 15(11.6) 
Gentamicin 14(4.8) 1(3.2) 0 11(10.6) 2(1.6) 
Tazocin 9(3.1) 0 0 4(3.8) 5(3.9) 
Cefriaxone 3(1.0) 1(3.2) 0 0(1.9) 2(1.6) 
NB: Amoclav = amoxicillin- clavulanic  
 
Surgical site infections 
 
Fifty two (13%) patients self-reported purulent discharge from operation sites. The diagnosis of an SSI 
was made by the doctor in 36 (9%) patients and positive cultures were reported in 20 (5%) patients. 
The rate of SSI among patients who underwent emergency and elective surgeries were 22 (8.5%) 
and 14 (9.9%) respectively. Culture positive SSI occurred in 11 (55%) emergency and in 9 (45%) 
elective operations. The majority (88.2%) of patients with culture positive SSI had not received pre-
operative antibiotics. Two thirds (65%) of the patients were women. Three of the patients who had 
positive culture results were HIV positive.  
 
The most common types of organisms isolated from the SSIs are shown in figure 1. Staphylococcus 
aureus, Pseudomonas auriginosa and Escherichia coli were the most common isolated pathogens. All 
these organisms were sensitive to cefotaxime, the most commonly used antibiotic. Escherichia coli, 
Klebsiella spp. and Citrobacter spp., were however resistant to cefotaxime. There was no sensitivity 
testing for metronidazole or cefradine. 
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Figure 1 - Organisms cultured from pus swabs of patients with SSI at PMH 
 
 
 
 
Discussion 
 
In this study, we found that approximately three-quarters (73%) of the patients received antibiotics 
peri-operatively, mostly after surgery. In addition, the majority of patients who had pre-operative 
antibiotics continued them post-operatively. The most frequently prescribed antibiotics were 
intravenous cefotaxime, cefradine and metronidazole. The incidence of SSIs was 8.8%, and about 
half (48.6%) of the patients with SSI had culture positive pus swabs.  
 
The SSI rate in this hospital in Botswana is lower than the pooled incidence rate of SSI of 14.8% 
reported in Africa by Andersen et al [5]. It is, however, comparable to the incidence rate of 9.2% 
reported by Ntsama et al among surgical patients in three public hospitals in Yaounde [35]. While the 
SSI rate in Botswana is also lower than in other developing countries, where rates as high as 41% 
have been reported, it is higher than findings from developed countries where it is reported 0 - 3% of 
surgical patients develop SSIs [7-9]. Nevertheless, it is difficult to compare incidence rates across 
countries due to variations in populations including co-morbidities, types of surgery, hospital sizes, 
experience of the surgeons and surveillance methods [3, 4].  One of the reasons for the apparent 
lower rate of SSIs in Botswana could be the high uptake of antibiotics peri-operatively. The use of 
antibiotics is reported to decrease the incidence of SSI by 39 %, primarily in those patients who 
receive antibiotics pre-operatively [23, 26]. However, as the majority of our patients received 
antibiotics post-operatively in our study, the lower incidence of SSIs cannot fully be explained by 
antibiotic use.  
 
Similar to findings from other studies, the most common organisms in the current study were 
Pseudomonas aeruginosa, Staphylococcus aureus, and coagulase-negative staphylococci [36-38]. 
*HQHUDOO\WKHFDXVDWLYHSDWKRJHQVIRU66,RULJLQDWHIURPWKHSDWLHQW¶VHQGRJHQRXVIORUDDQGGHSHQG
on the type and site of surgery [38].  
 
In addition to other measures, the World Health Organisation guidelines for the prevention of SSIs 
emphasize an optimal timing for preoperative antimicrobial prophylaxis when indicated [20]. In this 
study, we found that the timing of the initiation of antibiotics, antibiotic selection and duration of 
antibiotic prophylaxis were not according to the published guidelines [2, 13, 26]. The finding  is 
consistent with previous studies which revealed heterogeneity in antibiotic choices, timing and 
duration of antibiotic prophylaxis among surgical patients [39]. To prevent SSIs, the guidelines advise 
that antibiotic prophylaxis should be given 1-2 hours before a surgical incision for adequate serum 
and tissue drug levels to be achieved during surgery [13, 17, 22, 24-26]. Similar to findings by Gans et 
al. where  59% of patients in selected American hospitals continued antibiotics postoperatively, the 
majority of our patients received antibiotics after surgery [39]. Largely, the majority of our patients 
were administered antibiotics for a mean duration of 5 days. This is contrary to the evidence showing 
2
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that the administration of antibiotics after the incision is associated with an increased predisposition to 
antibiotic resistance and hospital costs compared with administration of antibiotics prior to the incision 
[20,29]. In actual fact, post-operative initiation of antibiotics has the same effect on preventing SSI as 
placebo [29, 40]. For reasons which could not be ascertained in this study, we also found that most of 
those patients who received pre-operative antibiotics continued with them postoperatively for an 
average of five days. As mentioned above, postoperative antibiotic administration is no better than the 
preoperative administration alone and may enhance resistance rates [20,29, 41]. Pre-operative use of 
antibiotics should therefore be encouraged in Botswana and we are now encouraging this in our 
hospital. This will be the subject of future research. 
 
Normally, selection of antibiotic prophylaxis should be based on multiple factors including the normal 
floral distribution of the site to be operated and the antibiotic resistance patterns in the hospital setting 
[1, 17, 27, 31, 32]. Usually, broad-spectrum antibiotics, especially cephalosporin, are preferred to 
narrow spectrum antibiotics [27]. Because of its longer half-life than other first-generation 
cephalosporin, a single dose of cefazolin has been ideal for many procedures [42].  As cefazolin is not 
available in our setting, the Botswana national guidelines recommend cefradine, a first-generation 
cephalosporin, for most procedures [33]. Despite this, cefradine was prescribed in only 13% of all 
patients who were administered antibiotics. The majority of our patients received cefotaxime, often in 
combination with metronidazole. This low compliance with the guideline not only increases hospital 
costs but also poses an increased risk of resistance to cefotaxime, increasing the occurrence of 
antibiotic resistance which we need to address [2]. 
 
Limitations 
 
We are aware that our study was only undertaken in one hospital in Botswana. However, as 
mentioned, this is a leading tertiary hospital in the country; consequently, a similar or worse picture is 
likely to be seen in secondary hospitals in Botswana. Although the exclusion of patients with 
prosthetic implants may have underestimated the incidence of SSI in our study, we included most of 
the surgeries encountered in most general hospitals in Botswana for comparative purposes.  Even so, 
surgical implantation of prostheses is not a common practice at PMH. Another limitation of the study 
was the reliance on surgeon¶V and anaesthetist¶V notes as evidence for pre-operative and 
intraoperative use of antibiotics. This is always a concern with such a methodology. Finally, we did not 
break SSI down into superficial, deep and organ/space related, and were unable to discuss the 
associated clinical consequences. Nevertheless, in view of our extensive methodology, we believe 
our findings are robust and provide guidance to this and other hospitals in Botswana as we seek to 
enhance the appropriate use of antibiotics in our country.  
 
Conclusion 
 
In conclusion, whilst our rate of SSIs at 8.8% appears lower than in other African countries, there are 
considerable areas for improvement to reduce the incidence of SSIs and potential AMR in Botswana. 
These include the timing of the prophylaxis, choice of antibiotics, and duration of prophylaxis beyond 
surgery. These findings call for interventions to improve the rational use of antibiotic prophylaxis to 
decrease the rate of SSIs in Botswana. We have already started these programmes in our hospital to 
address the concerns, and we will be following this up in future research projects. Research projects 
are also starting at other hospitals in Botswana building on these findings. 
 
Key points 
x Appropriate antibiotic prophylaxis is known to reduce the incidence of surgical site infections 
(SSIs), shorten hospital stay and reduce costs 
x Current guidelines recommend that the first dose of antibiotic prophylaxis should be given 1 ± 2 
hours before the first incision and not after the first incision or post operatively for maximum 
impact to reduce SSIs and potentially resistance rates. To maintain adequate drug concentration 
at surgical site, re-dosing is advised for surgeries that exceed 2 half-lives of the antimicrobial or if 
there is excessive blood loss. However, there is variation in the use of prophylactic antibiotics 
across countries, with the need for prophylaxis greater in lower and middle income countries with 
more complex cases 
x SSIs in this leading tertiary hospital in Botswana following antibiotic use and follow-up of patients 
up to 30 days post operatively was 8.8% 
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x Antibiotics were given in 73.3% of patients undergoing surgery, principally post-operatively 
(58.3%) with cefotaxime and metronidazole the most prescribed antibiotics 
x Concerns that the low compliance with Botswana guidelines will increase costs as well as 
increase resistance rates. These concerns are already resulting in interventions to try and 
address this in this and other hospitals in Botswana, which is being followed up   
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